carcinoma-associated antigen 494
a carbohydrate epitope on a high-molecular-weight-type glycoprotein
Networked: 2
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Colorectal Neoplasms (Colorectal Cancer)
|
2. | Pancreatic Neoplasms (Pancreatic Cancer)
03/01/2000
- " The correlation of CA 494 with CA 19-9 levels was lower (r = 0.532) than previously reported in pancreatic cancer." 03/12/1993
- " The sensitivity of pancreatic cancer was 90%, 44% and 90% for CA 19-9, CEA and CA 494, respectively. " 03/12/1993
- " In chronic pancreatitis, as the most important control population for pancreatic cancer, the specificity was 85%, 72% and 94% for CA 19-9, CEA and CA 494, respectively." 03/01/2000
- " CA 494 is a new carbohydrate epitope on a high-molecular-weight mucin-type glycoprotein which has been intensively investigated in pancreatic cancer. " 03/12/1993
- " In 59 patients with ductal pancreatic cancer the monoclonal antibody (MAb) BW 494, which detects the CA 494 glycoprotein antigen, was analyzed in comparison with the reference tumor markers CA 19-9 and CEA. "
|
3. | Chronic Pancreatitis
|
4. | Neoplasms (Cancer)
|
|
Related Drugs and Biologics